NASDAQ Index Blog - Archive Posts for June, 2015

Web Seminar Replay: Optimizing Behavioral Economics using Defined Outcome Investing Updated: 6/24/2015

 

Ever wonder what factors influence investment decisions? Expected returns play an obvious role, but not necessarily the most important one — behavioral factors also heavily influence investor decisions. Learn more about behavioral economics, including what drives it, how it influences portfolio construction, and how using defined outcome solutions can meet both return and behavioral needs better than traditional investment solutions.

Join Nasdaq Research; Joe Halpern, CEO, Exceed Investments; Dr. Menachem Brenner, finance professor at the Lenoard N. Stern School of Business at New York University and an international expert in derivative markets for a 60-minute web seminar where attendees will learn:

  • The behavioral responses to potential loss, risk, and ambiguity
  • How both human psychology and economic utility theory drive behavioral finance
  • How behavioral finance influences investment decisions
  • What are defined outcome investments
  • How defined outcome investments effectively balance investor returns and behavioral needs
WATCH THE REPLAY

Two New ProShares ETFs based on Nasdaq Biotech Index List on Nasdaq Updated: 6/24/2015



On June 23, 2015, ProShares listed two new ETFs, the UltraPro Nasdaq Biotechnology ETF (Symbol: UBIO) and UltraPro Short Nasdaq Biotechnology ETF (Symbol: ZBIO), tracking the Nasdaq Biotechnology Index on the Nasdaq Stock Market.

UBIO seeks to provide 3x and ZBIO seeks to provide -3x the daily performance of the Nasdaq Biotechnology Index, before fees and expenses. The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes Nasdaq-listed companies classified as either biotechnology or pharmaceutical.

The Nasdaq Biotechnology Index, which tracks a number of bellwether companies in the space, returned 34.1% in 2014, far outpacing both the S&P 500, and has continued its charge in 2015. Learn what is driving this growth story for the sector in our article, “Biotech – The Growth Story Continues.”

These products join six other global funds licensed to the index, including the ProShares Ultra Nasdaq Biotechnology ETF (BIB) and ProShares UltraShort Nasdaq Biotechnology ETF (BIS). ProShares is the world’s largest provider of geared ETFs. Geared ETFs are designed to offer knowledgeable investors the opportunity to act on their views, whether it’s hedging against downturns with inverse ETFs or using a leveraged ETF to get magnified exposure to a benchmark.

Nasdaq operates an efficient platform for successfully introducing a product suite into one of the single largest pools of liquidity, including market participants which represent a full spectrum of investors. ETF issuers benefit from an end-to-end solution that provides ongoing product support including index licensing, listings opportunities, data offerings and trading services.

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies or Nasdaq proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
 

Web Seminar Replay: Understanding the Dorsey Wright Indexes Methodology Updated: 6/23/2015

Dorsey, Wright & Associates, LLC, a Nasdaq Company, has been a financial industry leader in technical analysis and relative strength strategies for over 25 years. Join John Lewis, CMT, Senior Portfolio Manager, Dorsey Wright, and Dave Gedeon, Vice President, Nasdaq Global Indexes, for an in-depth look at the methodology behind some of the most well-known smart beta indexes in the world, which serve as the basis of ETFs with more than $8.2 billion in AUM.

This 30-minute seminar will provide an overview of Dorsey Wright’s relative strength strategies and a detailed look at the newly published methodology* of the following indexes:
  • Dorsey Wright Technical Leaders Index (DWTL)
  • Dorsey Wright Focus Five Index (DWANQFF)
  • Dorsey Wright International Focus Five Total Return (DWANQIFF)
  • DWA International Developed Markets Technical Leaders Index (DWADM) 
  • DWA International Emerging Markets Technical Leaders Index (DWAEM)
  • DWA Technical Leaders Small Cap Index (DWTLSC)
Thursday, June 18th
1:00 – 1:30 pm, ET
REGISTER NOW

May 2015 Monthly Index Performance Report By: Dave Gedeon
on 6/1/2015



Market performance in the month of May was driven by concerns about the economy’s health and the uncertainty of when the Fed will start to raise interest rates. In the background, news about the debt crisis in Greece also led media headlines.

The Nasdaq Biotechnology Index was May’s top performer with a 9.2% gain. The Nasdaq OMX Solar Index was the laggard for the month, shedding 8.4%. With its impressive gains, biotechnology continues to be a market leader in 2015. Despite a weak start to the month, the NASDAQ Composite rallied strongly to end the month higher by 2.6%, outperforming the 1.05% gain from the S&P 500. The Nasdaq Composite also crossed back above the key 5,000 level. Other notable strong performers include the Nasdaq PHLX Semiconductor Index (+8.6%), the Nasdaq Q-50 (+5.2%) and the Nasdaq OMX Wind Index (+7.5%).

The Nasdaq Biotechnology Index is May's top performer at 9.2% and the Nasdaq Solar Index is the worst performer of May at -8.4%. Get a quick overview of Nasdaq Index performance data for our top 50 most watched indexes here.

NASDAQ® and NASDAQ® are registered trademarks of The NASDAQ Group, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither The NASDAQ Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding NASDAQ-listed companies or NASDAQ proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

© 2015. The NASDAQ Group, Inc. All Rights Reserved.

Loading...
Account Sign In